Daré Bioscience Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Daré Bioscience stock has a consensus rating of "Strong Buy" and an average price target of $9.67. The average 1-year stock price forecast is 364.90% higher than the current stock price, while the lowest is $8.00 (+284.62%) and the highest is $12 (+476.92%).

Price Target: $9.67 (+364.90%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.00	$9.67	$9.00	$12
Change	+284.62%	+364.90%	+332.69%	+476.92%

* Price targets were last updated on May 19, 2026.

Analyst Ratings

The average analyst rating for Daré Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	2	2	2	2
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Buy Maintains $8	Buy	Maintains	$8	+284.62%	May 19, 2026
Douglas Tsao H.C. Wainwright	H.C. Wainwright	Buy Reiterates $12	Buy	Reiterates	$12	+476.92%	May 15, 2026

Financial Forecast

Revenue This Year

2.11M

from 1.03M

104.96%

from 1.03M

Revenue Next Year

7.39M

from 2.11M

249.97%

from 2.11M

EPS This Year

-0.95

from -1.20

EPS Next Year

-0.51

from -0.95

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	10.00M	2.81M	9.78K	1.03M	2.11M
Revenue Growth	-	-	-71.92%	-99.65%	10,429.36%	104.96%
Gross Profit	-100.00K	-20.14M	-18.83M	9.78K	734.39K	1.06M
Gross Margin	-	-201.42%	-670.62%	100.00%	71.29%	50.00%
Operating Income	-39.07M	-31.39M	-30.74M	-23.45M	-13.55M	-18.38M
Net Income	-38.70M	-30.95M	-30.16M	-4.05M	-13.40M	-18.42M
EPS	-	-	-	-	-1.20	-0.95
Free Cash Flow	-15.28M	-6.80M	-27.18M	-7.61M	-4.80M	129.39M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	5.7M
Avg	2.1M
Low	152,460

Revenue Growth

Revenue Growth	2026	2027	2028
High	453.3%
Avg	105.0%
Low	-85.2%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.95
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-